TFEB and metabolic dysfunction-associated steatotic liver disease: Importantly, studies on hepatic biopsies of patients with non-alcoholic fatty liver disease revealed that the lower the activity of TFEB, the more serious the liver steatosis and lipid aggregation (Zhang H. et al., 2018).